METHOD FOR ENHANCING REMYELINATION VIA CO-ADMINISTRATION OF MUSCARINIC RECEPTOR ANTAGONISTS AND VITAMIN D ANALOGUES
Disclosed herein are methods and compositions for treating a demyelinating disease, such as multiple sclerosis, by administering to a subject suffering the disease a combination of at least one muscarinic receptor antagonist and at least one vitamin D receptor agonist. L'invention concerne des...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ELIASOF, Scott BEYER, Brittney A LAIRSON, Luke L TAIT, Bradley D |
| description | Disclosed herein are methods and compositions for treating a demyelinating disease, such as multiple sclerosis, by administering to a subject suffering the disease a combination of at least one muscarinic receptor antagonist and at least one vitamin D receptor agonist.
L'invention concerne des méthodes et des compositions pour traiter une maladie démyélinisante, telle que la sclérose en plaques, par administration à un sujet atteint de la maladie d'une combinaison d'au moins un antagoniste du récepteur muscarinique et d'au moins un agoniste du récepteur de la vitamine D. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023225206A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023225206A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023225206A13</originalsourceid><addsrcrecordid>eNqNjE0KwjAQhbtxIeodBlwXaoruhyRNA82MJKniqhSJK9FCvT9G9ACu3g_ve8tidjq2rKBhD5paJGnJgNfuojtLGC0TnCyC5BKVs2RD9N-WG3B9kOhzKTMh9THmE6SIhj-7kL3KcMTMgcoJOza9DuticRvvc9r8dFVsGx1lW6bpOaR5Gq_pkV7DmUUlaiH2ojrgrv5v9QZ8lTmy</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD FOR ENHANCING REMYELINATION VIA CO-ADMINISTRATION OF MUSCARINIC RECEPTOR ANTAGONISTS AND VITAMIN D ANALOGUES</title><source>esp@cenet</source><creator>ELIASOF, Scott ; BEYER, Brittney A ; LAIRSON, Luke L ; TAIT, Bradley D</creator><creatorcontrib>ELIASOF, Scott ; BEYER, Brittney A ; LAIRSON, Luke L ; TAIT, Bradley D</creatorcontrib><description>Disclosed herein are methods and compositions for treating a demyelinating disease, such as multiple sclerosis, by administering to a subject suffering the disease a combination of at least one muscarinic receptor antagonist and at least one vitamin D receptor agonist.
L'invention concerne des méthodes et des compositions pour traiter une maladie démyélinisante, telle que la sclérose en plaques, par administration à un sujet atteint de la maladie d'une combinaison d'au moins un antagoniste du récepteur muscarinique et d'au moins un agoniste du récepteur de la vitamine D.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231123&DB=EPODOC&CC=WO&NR=2023225206A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231123&DB=EPODOC&CC=WO&NR=2023225206A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ELIASOF, Scott</creatorcontrib><creatorcontrib>BEYER, Brittney A</creatorcontrib><creatorcontrib>LAIRSON, Luke L</creatorcontrib><creatorcontrib>TAIT, Bradley D</creatorcontrib><title>METHOD FOR ENHANCING REMYELINATION VIA CO-ADMINISTRATION OF MUSCARINIC RECEPTOR ANTAGONISTS AND VITAMIN D ANALOGUES</title><description>Disclosed herein are methods and compositions for treating a demyelinating disease, such as multiple sclerosis, by administering to a subject suffering the disease a combination of at least one muscarinic receptor antagonist and at least one vitamin D receptor agonist.
L'invention concerne des méthodes et des compositions pour traiter une maladie démyélinisante, telle que la sclérose en plaques, par administration à un sujet atteint de la maladie d'une combinaison d'au moins un antagoniste du récepteur muscarinique et d'au moins un agoniste du récepteur de la vitamine D.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjE0KwjAQhbtxIeodBlwXaoruhyRNA82MJKniqhSJK9FCvT9G9ACu3g_ve8tidjq2rKBhD5paJGnJgNfuojtLGC0TnCyC5BKVs2RD9N-WG3B9kOhzKTMh9THmE6SIhj-7kL3KcMTMgcoJOza9DuticRvvc9r8dFVsGx1lW6bpOaR5Gq_pkV7DmUUlaiH2ojrgrv5v9QZ8lTmy</recordid><startdate>20231123</startdate><enddate>20231123</enddate><creator>ELIASOF, Scott</creator><creator>BEYER, Brittney A</creator><creator>LAIRSON, Luke L</creator><creator>TAIT, Bradley D</creator><scope>EVB</scope></search><sort><creationdate>20231123</creationdate><title>METHOD FOR ENHANCING REMYELINATION VIA CO-ADMINISTRATION OF MUSCARINIC RECEPTOR ANTAGONISTS AND VITAMIN D ANALOGUES</title><author>ELIASOF, Scott ; BEYER, Brittney A ; LAIRSON, Luke L ; TAIT, Bradley D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023225206A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ELIASOF, Scott</creatorcontrib><creatorcontrib>BEYER, Brittney A</creatorcontrib><creatorcontrib>LAIRSON, Luke L</creatorcontrib><creatorcontrib>TAIT, Bradley D</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ELIASOF, Scott</au><au>BEYER, Brittney A</au><au>LAIRSON, Luke L</au><au>TAIT, Bradley D</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD FOR ENHANCING REMYELINATION VIA CO-ADMINISTRATION OF MUSCARINIC RECEPTOR ANTAGONISTS AND VITAMIN D ANALOGUES</title><date>2023-11-23</date><risdate>2023</risdate><abstract>Disclosed herein are methods and compositions for treating a demyelinating disease, such as multiple sclerosis, by administering to a subject suffering the disease a combination of at least one muscarinic receptor antagonist and at least one vitamin D receptor agonist.
L'invention concerne des méthodes et des compositions pour traiter une maladie démyélinisante, telle que la sclérose en plaques, par administration à un sujet atteint de la maladie d'une combinaison d'au moins un antagoniste du récepteur muscarinique et d'au moins un agoniste du récepteur de la vitamine D.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2023225206A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | METHOD FOR ENHANCING REMYELINATION VIA CO-ADMINISTRATION OF MUSCARINIC RECEPTOR ANTAGONISTS AND VITAMIN D ANALOGUES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A09%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ELIASOF,%20Scott&rft.date=2023-11-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023225206A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |